Tiffany earned her Bachelor of Science in Pharmacy from Nanjing University of Chinese Medicine in 2021. She subsequently served as a research assistant at the Jiangsu Provincial Institute of Tumor Biotherapy, Xuzhou Medical University (2022–2024), where she engaged in CAR-T therapy research. In 2024, she commenced her master’s studies in Chinese Medicinal Science at Macau University of Science and Technology, joining the research team of Professor Vincent Kam Wai Wong. Her current research focuses on anti-fibroblast activation protein (FAP) CAR-Treg cell therapy for rheumatoid arthritis, aiming to develop novel immunotherapeutic strategies for autoimmune diseases.